Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT was delisted on the 1st of March, 2023.
10 hedge funds and large institutions have $1.25M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
+$518K |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$477K |
| 3 |
Morgan Stanley
New York
|
+$108K |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$78.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$37.3K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIM
1
Spark Investment Management
New York
| $511K | +$518K | +13,900 | New |
|
|
HCMT
2
Highland Capital Management (Texas)
Dallas,
Texas
| $471K | +$477K | +12,800 | New |
|
|
3
Morgan Stanley
New York
| $107K | +$108K | +2,899 | New |
|
|
OSAM
4
O'Shaughnessy Asset Management
Stamford,
Connecticut
| $77K | +$78.3K | +2,099 | New |
|
|
5
Bank of America
Charlotte,
North Carolina
| $37K | +$37.3K | +1,000 | New |
|
6
Wells Fargo
San Francisco,
California
| $12K | +$12.1K | +325 | New |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $11K | +$11.2K | +300 | New |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $11K | +$11.4K | +305 | New |
|
9
UBS Group
Zurich,
Switzerland
| $8K | +$8.13K | +218 | New |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| $7K | +$7.46K | +200 | New |
|
OPNT Hedge Fund Activity: Q3 2017 in Review
10 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Opiant Pharmaceuticals, Inc. Common Stock (OPNT) for Q3 2017, worth a combined $1.25M.
Buyers outnumbered sellers: 10 funds opened new OPNT positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Spark Investment Management, opening a new position worth an estimated $518K.
- 10 institutional investors held Opiant Pharmaceuticals, Inc. Common Stock (OPNT) as of Q3 2017, up from 0 in Q2 2017.
- Funds reported $1.25M of Opiant Pharmaceuticals, Inc. Common Stock stock for Q3 2017.
- 10 funds opened new Opiant Pharmaceuticals, Inc. Common Stock positions in Q3 2017 and 0 closed out, a net change of +10 holders.
- The largest Opiant Pharmaceuticals, Inc. Common Stock buyer in Q3 2017 was Spark Investment Management, an estimated $518K added.
Based on aggregated 13F filings for Q3 2017.